IOBT
IO Biotech
IOBT
IOBT
Delisted
IOBT was delisted on the 6th of April, 2026.
12 hedge funds and large institutions have $199K invested in IO Biotech in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
96% less capital invested
Capital invested by funds: $4.78M → $199K (-$4.58M)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$119K | |
| 2 | +$85.3K | |
| 3 | +$19.8K | |
| 4 |
Millennium Management
New York
|
+$18.9K |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$486K | |
| 3 | -$275K | |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$158K |
| 5 |
Renaissance Technologies
New York
|
-$126K |
